跳至主要内容
临床试验/NCT03885258
NCT03885258已完成早期 1 期

Melatonin Replacement Therapy Effects on Cardiac Autonomic Activity in Pinealectomized Patients

University of Sao Paulo1 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2017年5月2日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
5
试验地点
1
主要终点
cardiac autonomic function - heart rate variability

研究概览

简要总结

This is an open-label, single-arm, single-center, proof-of-concept study to assess the effects of melatonin on cardiac autonomic activity in melatonin non-proficient pinealectomized patients.

详细描述

This is an open-label, single-arm, single-center, proof-of-concept study to assess the effects of melatonin on cardiac autonomic activity in melatonin non-proficient pinealectomized patients. The study consists of a screening period, followed by a 3-month melatonin treatment period, and a 6-month washout follow-up period. Adverse events were monitored with respect to seriousness, intensity, relationship to treatment, action taken and outcome of the event.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

接受健康志愿者

入选标准

  • patients with pinealectomy and all of the following criteria were considered for admission to the clinical trial:
  • children, adolescents and young adults 0 months to 25 years of age;
  • signed written informed consent (patient or his/her parents/legal guardian);
  • willing and able to complete the clinical trial procedures, as described in the protocol
  • no recurring tumor after pinealectomy and subsequent chemotherapy
  • absence of circulating melatonin evaluated by salivary melatonin Elisa assay

排除标准

  • patients with cardiac arrhythmias
  • potentially non-compliant subjects judged by the investigator to be unsuitable for the study

研究组 & 干预措施

Melatonin Replacement Therapy

Experimental

Melatonin (Aché Pharmaceutics, Brazil) 3 mg, administered in the evening, 30 minutes before the usual bedtime, every day for 3 months. After discontinuation of melatonin therapy, patients are followed up for 6 months to assess safety parameters and cardiac autonomic activity.

干预措施: Melatonin Replacement Therapy (Drug)

结局指标

主要结局

cardiac autonomic function - heart rate variability

时间窗: 9 months

The cardiac autonomic function was determined through heart rate variability (HRV) measures after polysomnography ECG recordings.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ovidiu Constantin Baltatu

Co-PI to PI - José Cipolla-Neto

Anhembi Morumbi University

研究点 (1)

Loading locations...

相似试验

Melatonin Replacement Therapy in Pinealectomized... | 临床试验